Vladimir Kushnarev

8PUBLICATIONS
87CO-AUTHORS
Predictive and prognostic markersMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 06, 2026
Immunotherapy Response and Survival Outcome by Immunophenotypic Signature in Non-Small Cell Lung Cancer.

|Feb 20, 2025
The Breast Cancer Classifier refines molecular breast cancer classification to delineate the HER2-low subtype.

Polina Turova, Vladimir Kushnarev, Oleg Baranov

|Jan 25, 2025
Viral Transcript and Tumor Immune Microenvironment-Based Transcriptomic Profiling of HPV-Associated Head and Neck Squamous Cell Carcinoma Identifies Subtypes Associated with Prognosis.

Anastasiia Nikitina, Daria Kiriy, Andrey Tyshevich

|Dec 03, 2024
Duvelisib with Docetaxel for Patients with Anti-PD-1 Refractory, Recurrent, or Metastatic Head and Neck Squamous Cell Carcinoma.

Glenn J Hanna, L B Oakley, R Shi

|Nov 25, 2024
Response-Adaptive Surgical Timing in Neoadjuvant Immunotherapy Demonstrates Enhanced Pathologic Treatment Response in Head and Neck Squamous Cell Carcinoma.

Eric V Mastrolonardo, Kathryn L Nunes, Pablo Llerena

|Apr 06, 2021
[The use of intralaboratory and external quality control of immunohistochemical studies to improve the detection of estrogen and progesterone receptors].

V A Kushnarev, A G Kudaibergenova, L E Zavalishina

Pageof 2

Frequent Collaborators

2 joint publications

Nikita Kotlov

2 joint publications

Andrey Tyshevich

2 joint publications

Anastasiia Nikitina

1 joint publications

Janakiraman Subramanian